Anti-signal Recognition Particle Antibody-positive Necrotizing Myopathy with Secondary Cardiomyopathy: The First Myocardial Biopsy- and Multimodal Imaging-proven Case

A 69-year-old Japanese woman was admitted to our hospital with progressive muscle weakness and dysphagia. She was taking pitavastatin for dyslipidemia. Her serum creatine kinase was 6,300 U/L. Pitavastatin was stopped, but her symptoms deteriorated, and cardiac congestion appeared. A muscle biopsy s...

Full description

Saved in:
Bibliographic Details
Published inInternal Medicine Vol. 58; no. 21; pp. 3189 - 3194
Main Authors Takeguchi-Kikuchi, Shiori, Hayasaka, Taiki, Katayama, Takayuki, Kano, Kohei, Takahashi, Kae, Saito, Tsukasa, Sawada, Jun, Minoshima, Akiho, Sakamoto, Naka, Akasaka, Kazumi, Miyokawa, Naoyuki, Nishino, Ichizo, Ishibashi-Ueda, Hatsue, Hasebe, Naoyuki
Format Journal Article
LanguageEnglish
Published Japan The Japanese Society of Internal Medicine 01.11.2019
Japan Science and Technology Agency
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A 69-year-old Japanese woman was admitted to our hospital with progressive muscle weakness and dysphagia. She was taking pitavastatin for dyslipidemia. Her serum creatine kinase was 6,300 U/L. Pitavastatin was stopped, but her symptoms deteriorated, and cardiac congestion appeared. A muscle biopsy showed necrotizing myopathy (NM), and anti-signal recognition particle (SRP) antibody was positive. 18F-fluorodeoxyglucose-positron emission tomography showed an abnormal uptake, and magnetic resonance imaging showed abnormal gadolinium enhancement in the left ventricular wall. An endomyocardial biopsy revealed inflammatory cardiomyopathy. Steroid, tacrolimus, and intravenous immunoglobulins were effective against the symptoms. This is the first case of biopsy-proven secondary cardiomyopathy due to anti-SRP-positive NM.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
Correspondence to Dr. Takayuki Katayama, katataka@asahikawa-med.ac.jp
ISSN:0918-2918
1349-7235
DOI:10.2169/internalmedicine.2564-18